Amgen Inc. (AMGN)

219.31
4.40 2.00
NASDAQ : Health Technology
Prev Close 223.72
Open 223.49
Day Low/High 218.25 / 224.28
52 Wk Low/High 170.56 / 244.99
Volume 1.45M
Avg Volume 3.37M
Exchange NASDAQ
Shares Outstanding 588.25M
Market Cap 133.48B
EPS 13.00
P/E Ratio 17.77
Div & Yield 6.40 (2.66%)
7 Hot Investing Bets to Make in Biotech

7 Hot Investing Bets to Make in Biotech

These favorite names in the volatile sector offer the potential for high rewards.

Deciphering Wall Street's Differing Views of Amgen

Deciphering Wall Street's Differing Views of Amgen

What to make of the divergent views of Amgen's shares.

Deciphering the Amgen Enigma

Deciphering the Amgen Enigma

What to make of the divergent views of Amgen.

Some Afternoon Observations

* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF  has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

Biotech M&A activity will pick up markedly in 2018, and these companies are likely to be the most active in that space.

10 Biotech Stocks to Watch in 2018

10 Biotech Stocks to Watch in 2018

There are a variety of players that should be active in the M&A space next year.

The Good, the Bad and the Ugly (Monday Edition)

"If you work for a living, why do you kill yourself working?" -- Tuco, The Ugly: "The Good, the Bad and the Ugly" There was plenty of sector rotation today (but little overall movement), so let's move to the abbreviated Monarch Notes form of "Takeaw...

Paradise Lost

Trading shorts I should have kept on: * Electronic Arts LINK * Amgen LINK  

Who Benefits From Tax Reform?

Who Benefits From Tax Reform?

Technology and biotech companies seem to be among the big winners.

Tax Reform Will Be Hard to Push Through

Tax Reform Will Be Hard to Push Through

Without doubt, the tax reform plan would help the economy. But it's a hard sell politically.

Tax Reform Will Be Hard to Push Through

Tax Reform Will Be Hard to Push Through

Without doubt, the tax reform plan would help the economy. But it's a hard sell politically.

So Much for That Breakout

Well, I guess the technical breakout in Amgen was a false signal! From $187 to $171 in the last two weeks. I should not have covered my trading short rental! 

Argus Cuts Amgen to Hold

3 Small-Caps on My Growth Stock Radar

3 Small-Caps on My Growth Stock Radar

LGI Homes, ANI Pharmaceuticals and Sonus Networks are worth considering.

3 Biotech Stalwarts Just Can't Bio a Break

3 Biotech Stalwarts Just Can't Bio a Break

The stocks of Amgen, Celgene and Gilead Sciences all took hits after posting quarterly results.

Praise by Name, Criticize by Category

As an observation, I find -- and this is characteristic of a mature bull market -- that many investors, strategists, commentators and talking heads are just taking shots in the dark on stocks these days and are not adjusting their outlooks for chang...

Shorting More SPY on After Hours Rally

S&P futures rallied by about four handles after the close and I am aggressively adding to my SPDR S&P 500 ETF  short at $255.69. Amgen , -$7 was a post-market feature after the company's earnings release. Thanks so much for reading my Diary today an...

The Best Teacher is Your Last Mistake

Amgen is down by another $3. It was a mistake in covering.  

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

It looks like China is building again.

Nuts! Covered My Amgen Short Too Soon

It is said that your best teacher is your last mistake.   My last mistake was covering my trading short rental in Amgen too soon.

More Short 'Alpha' Today

I concluded yesterday with the following: Suffice to say, Mr. Market continued to show the sort of resiliency it has had for many months -- rallying from a 12-handle drop in the S&P Index to even at day's end. However, I did have one of my best shor...

Stocks Make it 5 for 5 This Week

Stocks Make it 5 for 5 This Week

Stocks log gains to mark perfect week of records.

Housekeeping: Amgen

I have covered my short trading rental in Amgen for a profit. The shares "appear" to have bottomed for the time being. Moving on!

Sticking With Amgen Short

I am sticking with my Amgen short though it is down by another $2 (now below $182).   This is another one confidently recommended in the business media because of the clear bullish chart pattern at $187 recently.   My strong suspicion is that if the...

Putting Off the Inevitable

Suffice to say, Mr. Market continued to show the sort of resiliency it has had for many months -- rallying from a 12-handle drop in the S&P Index to even at day's end.  However, I did have one of my best short alpha days in individual stocks, as I c...

Liking My Amgen Short

My Amgen short rental is working well.

Amgen Update

This morning I put on a trading short rental in Amgen  . The shares are now -$3 from the morning's highs.

It's As Easy As....1,2,3?

Based on my Twitter feed, the price chart (and technical positioning), my emails and other comments - the new stock du jour and fav trading stock is expected by many, to become Amgen .   The stock was recommended by two people I admire, Carter Worth...

Amgen Could Surge After a Pullback

Amgen Could Surge After a Pullback

We are seeing signs this pullback may nearly be over.

Amgen Gains Admirers, but I'll Pass

Based on my Twitter feed, the company's price chart and technical positioning, my emails and other comments, the new stock du jour and fav trading stock will now become Amgen .   While I admire the strong views for a host of reasons -- not the least...